This suggests that either promoter methylation does not play a key role in GLCE regulation in vivo and that other mechanisms overpower its effect, or clonal selection is directed toward the elimination of methylation-regulated cancer cell subtypes in favor of methylation-independent variants of prostate cancer cells. The gene discussed is GLCE; the disease is cancer.